Skip to main content

Table 3 Antimicrobial resistance pattern of E. coli and K. pneumoniae isolates from Hospital-acquired and Community-acquired urinary tract infections (% of resistance isolates within each group)

From: Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania

Antibiotic

E. coli (n = 110)

K. pneumoniae (n = 27)

Hospital acquired

Community acquired

Hospital acquired

Community acquired

ESBL (+)

(n = 11)

ESBL (−)

(n = 43)

ESBL (+)

(n = 4)

ESBL (−)

(n = 52)

ESBL (+)

(n = 4)

ESBL (−)

(n = 8)

ESBL (+)

(n = 5)

ESBL (−)

(n = 10)

AMC

NA

11.6

NA

17.3

NA

62.5

NA

30.0

CTX

NA

0

NA

0

NA

0

NA

0

CTZ

NA

0

NA

0

NA

0

NA

0

CRO

NA

0

NA

0

NA

0

NA

0

IMP

0

0

0

0

0

0

0

0

CHL

27.3

41.9

25.0

34.6

75.0

62.5

100

40.0

CIP

90.9

32.6

75.0

23.1

100

25.0

40.0

20.0

DOX

100

69.8

100

76.9

75.0

62.5

60.0

30.0

CN

90.9

16.3

50.0

21.2

100

37.5

80.0

10.0

NAL

90.0

41.9

75.0

34.6

100

25.0

40.0

30.0

NIT

27.3

27.3

50.0

50.0

100

100

60.0

60.0

SXT

90.9

62.8

100

80.8

75.0

87.5

60.0

60.0

  1. (+) = positive; (−) = negative
  2. AMC Amoxicillin-clavulanic acid, CTX cefotaxime, CTZ ceftazidime, CRO ceftriaxone, IMP imipenem, CHL chloramphenicol, CIP ciprofloxacin, DO doxycycline, CN gentamicin, NAL nalidixic acid, NIT nitrofurantoin, SXT trimethoprim-sulfamethoxazole